drugset

drugset / Trial / NCT02012569

Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting

NCT02012569 ↗

Phase 2 Completed 78 enrolled Thrombotargets Europe S.L

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the haemostatic efficacy of TT-173, reducing the bleeding time in the donor site of skin grafting.

Timeline

Start: 2013-11
Primary completion: 2015-07
Completion: 2015-07

Publications

Background Lopez-Lopez J, Jane-Salas E, Santamaria A, Gonzalez-Navarro B, Arranz-Obispo C, Lopez R, Miquel I, Arias B, Sanchez P, Rincon E, Rodriguez JR, Rojas S, Murat J. TETIS study: evaluation of new topical hemostatic agent TT-173 in tooth extraction. Clin Oral Investig. 2016 Jun;20(5):1055-63. doi: 10.1007/s00784-015-1586-1. Epub 2015 Sep 15.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TT-173	Unknown	—	Topical

Indications

No indication recorded.